Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $93.37 ($280,101)
  2. 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $95.35 ($1,239,608)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Executive Officer sold 45,626 shares at $90.07 ($4,109,534)
  11. 4 Open-market sale Chief Executive Officer sold 49,374 shares at an average $90.40 ($4,463,524)
  12. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $85.76 ($175,808)
  13. 4 Open-market sale Chief Scientific Officer sold 15,177 shares at $90.00 ($1,365,930)
  14. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $85.00 ($170,003)
  15. 4 Open-market sale Chief Medical Officer sold 2,000 shares at $81.38 ($162,760)
  16. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at $81.81 ($245,430)
  17. 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $83.04 ($1,079,501)
  18. 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $85.95 ($176,198)
  19. 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $85.10 ($170,190)
  20. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $75.20 ($225,607)

Page 21 of 38 · 758 filings